Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system.
2002
This study was designed to assess the effects of rivastigmine (Exelon®) on the cognitive functioning of patients suffering from dementia with Lewy bodies. This was a prospective, multi-cent
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
196
Citations
NaN
KQI